vimarsana.com
Home
Live Updates
Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinic
Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinic
Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinical Trial Evaluating EVO100 for Prevention of Chlamydia and Gonorrhea Infection in Women
/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) announced today that the recently completed Phase 3 EVOGUARD clinical trial evaluating EVO100 for the...
Related Keywords
Amy Raskopf ,
Evofem Bioscience ,
Clint Dart ,
Evofem Biosciences ,
Saundra Pelletier ,
Brandi Howard ,
Lisa Rarick ,
Securities Exchange ,
Evofem Biosciences Inc ,
Prnewswire Evofem Biosciences Inc ,
Chief Executive Officer ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Report ,
Nc ,